The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review
Open accessAbstract
There is increasing recognition of the importance of blood-brain barrier (BBB) disruption in aging, dementia, stroke and multiple sclerosis in addition to more commonly-studied pathologies such as tumors. Dynamic contrast-enhanced MRI (DCE-MRI) is a method for studying BBB disruption in vivo. We review pathologies studied, scanning protocols and data analysis procedures to determine the range of available methods and their suitability to different pathologies. We systematically review the existing literature up to February 2014, seeking studies that assessed BBB integrity using T1-weighted DCE-MRI techniques in animals and humans in normal or abnormal brain tissues. The literature search provided 70 studies that were eligible for inclusion, involving 417 animals and 1564 human subjects in total. The pathologies most studied are intracranial neoplasms and acute ischemic strokes. There are large variations in the type of DCE-MRI sequence, the imaging protocols and the contrast agents used. Moreover, studies use a variety of different methods for data analysis, mainly based on model-free measurements and on the Patlak and Tofts models. Consequently, estimated K (Trans) values varied widely. In conclusion, DCE-MRI is shown to provide valuable information in a large variety of applications, ranging from common applications, such as grading of primary brain tumors, to more recent applications, such as assessment of subtle BBB dysfunction in Alzheimer's disease. Further research is required in order to establish consensus-based recommendations for data acquisition and analysis and, hence, improve inter-study comparability and promote wider use of DCE-MRI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452 · cited 3×
“Several comprehensive reviews provide detailed information on themolecular biology of BBB disruption in disease (Abbott and Friedman, 2012; Obermeier et al., 2013; Rosenberg, 2012).”
Tofts, P. S., & Kermode, A. G. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910170208 · Cited by 1,456
Parker, G. J. M., Roberts, C., Macdonald, A., Buonaccorsi, G. A., Cheung, S., Buckley, D. L., Jackson, A., Watson, Y., Davies, K., & Jayson, G. C. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21066 · Cited by 660
Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging
Brix, G., Semmler, W., Port, R., Schad, L. R., Layer, G., & Lorenz, W. J. (1991) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199107000-00018 · Cited by 659
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
Weinmann, H., Laniado, M., & Mutzel, W. (1984) · PubMed · Cited by 462
Neurological Diseases in Relation to the Blood–Brain Barrier
Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 445
Starr, J. M. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.70 · Cited by 434
Classic models for dynamic contrast‐enhanced MRI
Sourbron, S. P., & Buckley, D. L. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2940 · Cited by 434
Larsson, H. B. W., Stubgaard, M., Frederiksen, J. L., Jensen, M., Henriksen, O., & Paulson, O. B. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910160111 · Cited by 431
Roberts, H. C., Roberts, T. P. L., Brasch, R. C., & Dillon, W. P. (2000) · PubMed Central · Cited by 427
On the scope and interpretation of the Tofts models for DCE‐MRI
Sourbron, S. P., & Buckley, D. L. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22861 · Cited by 371
Lacunar stroke is associated with diffuse blood-brain barrier dysfunction
Wardlaw, J. M., Doubal, F., Armitage, P., Chappell, F., Carpenter, T., Muñoz Maniega, S., Farrall, A., Sudlow, C., Dennis, M., & Dhillon, B. (2009) · Annals of Neurology · doi:10.1002/ana.21549 · Cited by 364 · cited 6×
“Ten studies delivered a fi xed quantity of contrast agent, ranging between 7.5 mmol (Kassner et al., 2009; Vidarsson et al., 2009; Thornhill et al., 2010) and 20 mmol (Wardlaw et al., 2008; Wardlaw et al., 2009; Armitage et al., 2011) in humans.”
InfluentialSelf-citationOverview and introduction: The blood–brain barrier in health and disease
Abbott, N. J., & Friedman, A. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03696.x · Cited by 362
Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability
Sourbron, S. P., & Buckley, D. L. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/2/r1 · Cited by 361
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
O'Connor, J. P. B., Jackson, A., Parker, G. J. M., Roberts, C., & Jayson, G. C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.2 · Cited by 348
Topakian, R., Barrick, T. R., Howe, F. A., & Markus, H. S. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.172072 · Cited by 281
Sourbron, S., Ingrisch, M., Siefert, A., Reiser, M., & Herrmann, K. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22005 · Cited by 276
Blood-brain barrier permeability abnormalities in vascular cognitive impairment
Taheri, S., Gasparovic, C., Huisa, B. N., Adair, J. C., Edmonds, E., Prestopnik, J., Grossetete, M., Shah, N. J., Wills, J., Qualls, C., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.611731 · Cited by 248 · cited 12×
“…stroke and/or cerebrovascular disease (Kassner et al., 2009; Wardlaw et al., 2008; Wardlaw et al., 2009; Topakian et al., 2010; Armitage et al., 2011; Aksoy et al., 2013; Vidarsson et al., 2009; Kassner et al., 2005; Thornhill et al., 2010; Taheri et al., 2011a,b) with a total of 482/1564 subjects.”
InfluentialCramer, S. P., Simonsen, H., Frederiksen, J. L., Rostrup, E., & Larsson, H. B. W. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.12.001 · Cited by 232 · cited 9×
“…(Starr et al., 2003), vascular cognitive impairment (Taheri et al., 2011a), normal-appearing and lesion tissue in multiple sclerosis patients (Cramer et al., 2014; Taheri et al., 2011b), mild cognitive impairment (Taheri et al., 2011b), zinc de fi ciency (Noseworthy and Bray, 2000) and small…”
InfluentialLarsson, H. B. W., Courivaud, F., Rostrup, E., & Hansen, A. E. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22136 · Cited by 224
Schabel, M. C., & Parker, D. L. (2008) · Physics in Medicine and Biology · doi:10.1088/0031-9155/53/9/010 · Cited by 221
Arterial input function in perfusion MRI: A comprehensive review
Calamante, F. (2013) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2013.04.002 · Cited by 219
Kermode, A. G., Tofts, P. S., Thompson, A. J., MacManus, D. G., Rudge, P., Kendall, B. E., Kingsley, D. P. E., Moseley, I. F., Boulay, E. P. G. H. D., & McDonald, W. I. (1990) · Neurology · doi:10.1212/wnl.40.2.229 · Cited by 215
Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study
Starr, J. M., Farrall, A. J., Armitage, P., McGurn, B., & Wardlaw, J. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.04.003 · Cited by 189
Self-citationEwing, J. R., Knight, R. A., Nagaraja, T. N., Yee, J. S., Nagesh, V., Whitton, P. A., Li, L., & Fenstermacher, J. D. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10524 · Cited by 181
Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors
Li, K.-L., Zhu, X. P., Waterton, J., & Jackson, A. (2000) · Journal of Magnetic Resonance Imaging · doi:10.1002/1522-2586(200008)12:2<347::aid-jmri19>3.0.co;2-7 · Cited by 180
Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions
Gaitán, M. I., Shea, C. D., Evangelou, I. E., Stone, R. D., Fenton, K. M., Bielekova, B., Massacesi, L., & Reich, D. S. (2011) · Annals of Neurology · doi:10.1002/ana.22472 · Cited by 174 · cited 4×
“Model-free methods included the visual assessment of spatiotemporal enhancement patterns in multiple sclerosis lesions (Kermode et al., 1990; Gaitán and Shea, 2011; Shinohara et al., 2011), calculation of semi-quantitative parameters from the signal Fig.”
InfluentialShames, D. M., Kuwatsuru, R., Vexler, V., Mühler, A., & Brasch, R. C. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910290506 · Cited by 172
Leach, M. O., Morgan, B., Tofts, P. S., Buckley, D. L., Huang, W., Horsfield, M. A., Chenevert, T. L., Collins, D. J., Jackson, A., Lomas, D. J., et al. (2012) · European Radiology · doi:10.1007/s00330-012-2446-x · Cited by 160
A new muscle glycogen storage disease associated with glycogenin-1 deficiency
(2014) · DIAL (Catholic University of Leuven) · doi:10.1002/ana · Cited by 155
Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging
Su, M., Head, E., Brooks, W. M., Wang, Z., Muggenburg, B. A., Adam, G. E., Sutherland, R. J., Cotman, C. W., & Nalcioğlu, O. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00081-5 · Cited by 141
Larsson, H. B. W., Frederiksen, J. L., Kjær, L., Henriksen, O. M., & Olesen, J. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910070106 · Cited by 129
Brookes, J. A., Redpath, T. W., Gilbert, F. J., Murray, A. D., & Staff, R. T. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199902)9:2<163::aid-jmri3>3.0.co;2-l · Cited by 118
Cramer, S. P., & Larsson, H. B. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.126 · Cited by 117
Larsen, V. A., Simonsen, H. J., Law, I. G., Larsson, H. B. W., & Hansen, A. E. (2012) · Neuroradiology · doi:10.1007/s00234-012-1127-4 · Cited by 112
Taheri, S., Gasparovic, C., Shah, N. J., & Rosenberg, G. A. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22686 · Cited by 111
Ewing, J. R., & Bagher‐Ebadian, H. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2996 · Cited by 107
Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging.
Kassner, A., Roberts, T. P. L., Taylor, K. S., Silver, F. L., & Mikulis, D. J. (2005) · PubMed · Cited by 107
Ingrisch, M., Sourbron, S., Morhard, D., Ertl-Wagner, B., Kümpfel, T., Hohlfeld, R., Reiser, M., & Glaser, C. (2012) · Investigative Radiology · doi:10.1097/rli.0b013e31823bfc97 · Cited by 106
Wang, H., Golob, E. J., & Su, M. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20669 · Cited by 106
Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications
Jain, R. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2994 · Cited by 95
Singh, A. K., Haris, M., Rathore, D., Purwar, A., Sarma, M. K., Bayu, G., Husain, N., Rathore, R. K. S., & Gupta, R. K. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21080 · Cited by 95
Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI
Haris, M., Gupta, R. K., Singh, A. K., Husain, N., Husain, M., Pandey, C. M., Srivastava, C., Behari, S., & Rathore, R. K. S. (2008) · Neuroradiology · doi:10.1007/s00234-008-0378-6 · Cited by 92
Use of dynamic contrast-enhanced MRI to measure subtle blood–brain barrier abnormalities
Armitage, P. A., Farrall, A., Carpenter, T. K., Doubal, F., & Wardlaw, J. M. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.09.002 · Cited by 91
Self-citationKassner, A., Roberts, T. P. L., Moran, B., Silver, F. L., & Mikulis, D. J. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1774 · Cited by 89
Wardlaw, J. M., Farrall, A., Armitage, P. A., Carpenter, T., Chappell, F., Doubal, F., Chowdhury, D., Cvoro, V., & Dennis, M. S. (2008) · Stroke · doi:10.1161/strokeaha.107.500124 · Cited by 87 · cited 6×
“Ten studies delivered a fi xed quantity of contrast agent, ranging between 7.5 mmol (Kassner et al., 2009; Vidarsson et al., 2009; Thornhill et al., 2010) and 20 mmol (Wardlaw et al., 2008; Wardlaw et al., 2009; Armitage et al., 2011) in humans.”
InfluentialSelf-citationBarnes, S. L., Whisenant, J. G., Loveless, M. E., & Yankeelov, T. E. (2012) · Pharmaceutics · doi:10.3390/pharmaceutics4030442 · Cited by 87
Lüdemann, L., Hamm, B., & Zimmer, C. (2000) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(00)00223-x · Cited by 85
Post-ischemic blood–brain barrier leakage in rats: One-week follow-up by MRI
Durukan, A., Marinković, I., Strbian, D., Pitkonen, M., Pedrono, E., Soinne, L., Abo‐Ramadan, U., & Tatlisumak, T. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.025 · Cited by 82
Simplified, noninvasive PET measurement of blood-brain barrier permeability.
Iannotti, F., Fieschi, C., Alfano, B., Picozzi, P., Mansi, L., Pozzilli, C., Punzo, A., del Vecchio, G., Lenzi, G. L., & Salvatore, M. (1987) · Journal of computer assisted tomography · doi:10.1097/00004728-198705000-00004 · Cited by 80
Lüdemann, L., Warmuth, C., Plotkin, M., Förschler, A., Gutberlet, M., Wust, P., & Amthauer, H. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.012 · Cited by 78
Ali, M. M., Janic, B., Abbas Babajani-feremi, A., Varma, N. R. S., Iskander, A., Anagli, J. Y., & Arbab, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008727 · Cited by 77
Lavini, C., & Verhoeff, J. J. C. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.06.017 · Cited by 76
Armitage, P. A., Behrenbruch, C. P., Brady, M., & Moore, N. (2005) · Medical Image Analysis · doi:10.1016/j.media.2005.01.001 · Cited by 75
Model selection for DCE‐T1 studies in glioblastoma
Bagher‐Ebadian, H., Jain, R., Nejad‐Davarani, S. P., Mikkelsen, T., Lü, M., Jiang, Q., Scarpace, L. M., Arbab, A. S., Narang, J., Soltanian‐Zadeh, H., et al. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.23211 · Cited by 75
Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI
Gupta, R. K., Awasthi, R., Rathore, R. K. S., Verma, A., Sahoo, P., Paliwal, V. K., Prasad, K. N., Pandey, C. M., & Narayana, P. A. (2012) · Neurology · doi:10.1212/wnl.0b013e318248deae · Cited by 74
Dual dynamic contrast‐enhanced MR imaging
Miyati, T., Banno, T., Mase, M., Kasai, H., Shundo, H., Imazawa, M., & Ohba, S. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070136 · Cited by 69
Ferrier, M. C., Sarin, H., Fung, S. H., Schatlo, B., Pluta, R. M., Gupta, S., Choyke, P. L., Oldfield, E. H., Thomasson, D. M., & Butman, J. A. (2007) · Neoplasia · doi:10.1593/neo.07289 · Cited by 69
Abo‐Ramadan, U., Durukan, A., Pitkonen, M., Marinković, I., Tatlısumak, E., Pedrono, E., Soinne, L., Strbian, D., & Tatlisumak, T. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.06.002 · Cited by 66
Aksoy, D., Bammer, R., Mlynash, M., Venkatasubramanian, C., Eyngorn, I., Snider, R. W., Gupta, S., Narayana, R., Fischbein, N. J., & Wijman, C. A. C. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000161 · Cited by 63
Jelescu, I., Leppert, I. R., Narayanan, S., Araújo, D., Arnold, D. L., & Pike, G. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22565 · Cited by 58
Noseworthy, M. D., & Bray, T. Μ. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22324.x · Cited by 51
Thornhill, R. E., Chen, S., Rammo, W., Mikulis, D. J., & Kassner, A. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2003 · Cited by 43
Song, S., Lee, S., Lee, J. J., Lee, J. E., Choi, H. S., Sohn, Y. H., & Lee, P. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.017 · Cited by 42
Shinohara, R. T., Crainiceanu, C. M., Caffo, B. S., Gaitán, M. I., & Reich, D. S. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.038 · Cited by 42
Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors
Thompson, E. M., Guillaume, D. J., Dósa, E., Li, X., Nazemi, K. J., Gahramanov, S., Hamilton, B. E., & Neuwelt, E. A. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0872-x · Cited by 41
Haris, M., Husain, N., Singh, A. K., Husain, M., Srivastava, S., Srivastava, C., Behari, S., Rathore, R. K. S., Saksena, S., & Gupta, R. K. (2008) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e31816200d1 · Cited by 40
Taheri, S., Candelario‐Jalil, E., Estrada, E. Y., & Rosenberg, G. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006597 · Cited by 39
Larsson, C., Kleppestø, M., Rasmussen, I., et al. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23866 · Cited by 37
Haris, M., Husain, N., Singh, A. K., Awasthi, R., Rathore, R. K. S., Husain, M., & Gupta, R. K. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21491 · Cited by 35
Chen, J., Yao, J., & Thomasson, D. M. (2008) · Lecture notes in computer science · doi:10.1007/978-3-540-85988-8_71 · Cited by 35
Ferl, G. Z., Xu, L., Friesenhahn, M. J., Bernstein, L. J., Barboriak, D. P., & Port, R. E. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22335 · Cited by 34
Li, K., Buonaccorsi, G. A., Thompson, G., Cain, J. R., Watkins, A., Russell, D., Qureshi, S., Evans, D. G., Lloyd, S., Zhu, X., et al. (2012) · Magnetic Resonance in Medicine · doi:10.1002/mrm.23252 · Cited by 33
Budde, M. D., Gold, E. M., Jordan, E. K., & Frank, J. A. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9428-2 · Cited by 31
DCE and DW‐MRI monitoring of vascular disruption following VEGF‐Trap treatment of a rat glioma model
Hoff, B. A., Bhojani, M. S., Rudge, J. S., Chenevert, T. L., Meyer, C. R., Galbán, S., Johnson, T. D., Sebolt, J. S., Rehemtulla, A., Ross, B. D., et al. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1814 · Cited by 29
Vidarsson, L., Thornhill, R. E., Liu, F., Mikulis, D. J., & Kassner, A. (2009) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2009.01.019 · Cited by 28
Wei, X., Wang, D., Li, M., Zhang, Y., Li, Y., & Li, W. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31823498eb · Cited by 24
Awasthi, R., Pandey, C. M., Sahoo, P., Behari, S., Kumar, V., Kumar, S., Misra, S., Husain, N., Soni, P., Rathore, R. K. S., et al. (2012) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e31823f6c59 · Cited by 23
Pharmacokinetic Modeling of Gd-DTPA Extravasation in Brain Tumors
Lüdemann, L., Wurm, R. E., & Zimmer, C. (2002) · Investigative Radiology · doi:10.1097/00004424-200210000-00005 · Cited by 23
A new denoising method for dynamic contrast-enhanced MRI
Gal, Y., Mehnert, A., Bradley, A. P., McMahon, K., Kennedy, D., & Crozier, . (2008) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2008.4649286 · Cited by 3
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
What are White Matter Hyperintensities Made of?: Relevance to Vascular Cognitive Impairment
Wardlaw, J. M., Valdés Hernández, M. C., & Muñoz‐Maniega, S. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001140 · Cited by 902
Self-citationNeuronal regulation of the blood–brain barrier and neurovascular coupling
Kaplan, L., Chow, B. W., & Gu, C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0322-2 · Cited by 430
Daulatzai, M. A. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23777 · Cited by 429
Bernardo-Castro, S., Sousa, J. A., Brás, A., Cecília, C., Rodrigues, B., Almendra, L., Machado, C., Santo, G., Silva, F., Ferreira, L., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.594672 · Cited by 381
Metadata
- Authors
- Heye, A. K., Culling, R. D., Valdés Hernández, M. D. C., Thrippleton, M. J., & Wardlaw, J. M.
- Venue
- NeuroImage: Clinical
- Publisher
- Elsevier BV
- Published
- 2014
- Volume
- 6
- Pages
- 262-274
- ISSN
- 2213-1582 (ISSN-L)
- OpenAlex
- W2168127946
- Cited by
- 406
- References
- 82
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.